`Case 2:20-cv-00337-JRG Document 351 Filed 03/21/22 Page 1 of 5 PageID #: 12622
`
`IN THE UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Defendant, and
`
`
`ASTRAZENECA PHARMACEUTICALS
`LP and ASTRAZENECA UK LTD.,
`
`
`
`
`SEAGEN INC.,
`
`
`
`
`v.
`
`Plaintiff,
`
`
`DAIICHI SANKYO CO., LTD.,
`
`
`
`
`
`
`
`
`CASE NO. 2:20-cv-00337-JRG
`
`
`
`
`
`Intervenor-Defendants.
`
`
`
`
`
`DEFENDANTS’ FIRST AMENDED LIST OF TRIAL WITNESSES
`
`Pursuant to Rule 26(a)(3) of the Federal Rules of Civil Procedure and the Court’s First
`
`Amended Docket Control Order (Dkt. No. 229) Daiichi Sankyo Company, Limited,
`
`AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Ltd. (“Defendants”) respectfully
`
`submit the following first amended list of witnesses that Defendants expect to present at trial
`
`and those that Defendants may call at trial if the need arises (either in person, through
`
`deposition designations, or through videotaped deposition).
`
`Defendants submit this first amended witness list without waiving any rights,
`
`including the right to supplement or amend the list. Defendants also may call as a witness any
`
`person identified on the witness list submitted by Plaintiff. Defendants also may call
`
`witnesses not included on this list in rebuttal. The inclusion of witnesses on this list is subject
`
`to any pretrial motions.
`
`
`
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 351 Filed 03/21/22 Page 2 of 5 PageID #: 12623
`
`May Call Live
`X
`
`May Call By
`Deposition
`X
`
`X
`
`X
`
`X
`
`X
`X
`X
`X
`
`X
`X
`X
`X
`X
`
`X
`X
`X
`X
`
`X
`X
`X
`X
`X
`
`WITNESS
`
`Will Call Live
`
`Scott Alban, J.D.,
`Ph.D.
`Glenn Gormley, M.D.,
`Ph.D.
`Naomi Ko, M.D.,
`M.P.H.
`John Lambert, Ph.D.
`Philip Howard, Ph.D.
`David Manspeizer
`Christine Meyer,
`Ph.D.
`Hiroyuki Naito, Ph.D.
`Stephen Alley, Ph.D.
`Kent Barnes
`Patrick Burke, Ph.D.
`Svetlana Doronina,
`Ph.D.
`Scott Jeffrey, Ph.D.
`Ashutosh Joshi
`Toni Kline, Ph.D.
`Robert Kolakowski,
`Ph.D.
`Robert Lyon, Ph.D.
`Damon Meyer, Ph.D.
`Peter Senter, Ph.D.
`Todd Simpson
`Brian Toki, Ph.D.
`
`
`
`
`
`X
`
`X
`
`X
`X
`
`X
`
`X
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`- 2 -
`
`
`
`
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 351 Filed 03/21/22 Page 3 of 5 PageID #: 12624
`
`Dated: March 21, 2022
`
`
`
`
`
`
`
`
`
`
`/s/ Preston K. Ratliff II
`
`Deron R. Dacus
`State Bar No. 00790553
`The Dacus Firm, P.C.
`821 ESE Loop 323, Suite 430
`Tyler, Texas, 75701
`+1 (903) 705-1117
`+1 (903) 581-2543 facsimile
`ddacus@dacusfirm.com
`
`J. Mark Mann
`State Bar No. 12926150
`mark@themannfirm.com
`MANN | TINDEL | THOMPSON
`300 West Main Street
`Henderson, Texas 75652
`(903) 657-8540
`(903) 657-6003 (fax)
`
`Attorneys for Defendant Daiichi
`Sankyo Company, Limited
`
`OF COUNSEL:
`
`Preston K. Ratliff II
`Ashley N. Mays-Williams
`Paul Hastings LLP
`200 Park Avenue
`New York, NY 10166
`(212) 318-6000
`
`Jeffrey A. Pade
`Paul Hastings LLP
`2050 M Street NW
`Washington, DC 20036
`(202) 551-1700
`
`Attorneys for Defendant Daiichi
`Sankyo Company, Limited
`
`
`
`
`
`- 3 -
`
`
`
`
`Case 2:20-cv-00337-JRG Document 351 Filed 03/21/22 Page 4 of 5 PageID #: 12625
`
`/s/ David Berl
`
`Jennifer Parker Ainsworth
`Texas State Bar No. 00784720
`WILSON, ROBERTSON &
`CORNELIUS, P.C.
`909 ESE Loop 323, Suite 400
`Tyler, Texas 75701
`Phone: (903) 509-5000
`Facsimile: (903) 509-5092
`
`Attorney for Intervenor-Defendants
`AstraZeneca Pharmaceuticals LP
`and AstraZeneca UK Ltd.
`
`OF COUNSEL
`
`David I. Berl
`Thomas S. Fletcher
`Jessica L. Pahl
`Kathryn Kayali
`Kevin Hoagland-Hanson
`Andrew Hoffman
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`Phone: (202) 434-5000
`Facsimile: (202) 434-5029
`
`Attorneys for Intervenor-
`Defendants AstraZeneca
`Pharmaceuticals LP and
`AstraZeneca UK Ltd.
`
`
`
`
`
`
`
`
`
`
`
`- 4 -
`
`
`
`
`Case 2:20-cv-00337-JRG Document 351 Filed 03/21/22 Page 5 of 5 PageID #: 12626
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that all counsel of record who have consented to
`
`electronic service are being served with a copy of this document via electronic mail on March
`
`21, 2022.
`
`/s/ Preston K. Ratliff II
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`